Russell Frank Company’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Russell Frank Company’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,106,000	Closed	-$591K	–	3121
2014 Q4	$591K	Sell	1,106,000 -150,300	-12%	-$90.9K	﹤0.01%	2353
2014 Q3	$722K	Buy	1,256,300 +19,200	+2%	+$24.3K	﹤0.01%	2216
2014 Q2	$1.69M	Buy	1,237,100 +231,200	+23%	+$331K	﹤0.01%	1839
2014 Q1	$1.51M	Hold	1,005,900	–	–	﹤0.01%	1900
2013 Q4	$1.55M	Buy	1,005,900 +712,500	+243%	+$1.61M	﹤0.01%	1863
2013 Q3	$714K	Sell	293,400 -479,900	-62%	-$1.33M	﹤0.01%	2347
2013 Q2	$2.2M	Buy	+773,300	New	+$2.14M	﹤0.01%	1710

Other funds holding ONCY

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

NCCM

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Russell Frank Company's ONCY Position: Q1 2015 in Review

Russell Frank Company sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2015, closing a stake of 1,106,000 shares — an estimated $591K sold.

Russell Frank Company first reported a position in ONCY in Q2 2013 and held it in 7 quarters. The position peaked at $2.2M in Q2 2013. 29 funds tracked by Wall St. Rank hold ONCY as of Q1 2015.

Russell Frank Company reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2015 after selling out during the quarter.
Russell Frank Company sold 1,106,000 ONCOLYTICS BIOTECH INC shares in Q1 2015, an estimated $591K.
Russell Frank Company first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 7 quarters.
Russell Frank Company's ONCOLYTICS BIOTECH INC position peaked at $2.2M in Q2 2013.
29 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2015.

Based on Russell Frank Company's 13F filing for Q1 2015, filed 13 May 2015.